FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034803529> ?p ?o ?g. }

• W2034803529 abstract "Combination vaccines improve coverage, compliance and effectively introduce new antigens to mass vaccination programmes. This was a phase III, observer-blind, randomized study of GSK Biologicals diphtheria-tetanus-whole cell pertussis vaccine combined with hepatitis B and Haemophilus influenzae type b vaccines, containing a reduced amount of polyribosyl-ribitol-phosphate (PRP) and a DTPw component manufactured at a different site (DTPw-HBV/Hib2.5 [Kft]). The primary aim of this study was to demonstrate that DTPw-HBV/Hib2.5 [Kft] was not inferior to the licensed DTPw-HBV/Hib (Tritanrix(tm)-HepB/Hiberix(tm)) vaccine or the DTPw-HBV/Hib2.5 vaccine, also containing a reduced amount of PRP, with respect to the immune response to the PRP antigen, when administered to healthy infants, according to the Expanded Programme for Immunization (EPI) schedule at 6, 10 and 14 weeks of age.299 healthy infants were randomised to receive either DTPw-HBV/Hib2.5 [Kft] DTPw-HBV/Hib2.5 or DTPw-HBV/Hib according to the 6-10-14 week EPI schedule. Blood samples were analysed prior to the first dose of study vaccine and one month after the third vaccine dose for the analysis of immune responses. Solicited local and general symptoms such as pain, redness and swelling at the injection site and drowsiness and fever, unsolicited symptoms (defined as any additional adverse event) and serious adverse events (SAEs) were recorded up to 20 weeks of age.One month after the third vaccine dose, 100% of subjects receiving DTPw-HBV/Hib2.5 [Kft] or DTPw-HBV/Hib and 98.8% of subjects receiving DTPw-HBV/Hib2.5 vaccine had seroprotective levels of anti-PRP antibodies (defined as anti-PRP antibody concentration ≥0.15 μg/ml). Seroprotective antibody concentrations were attained in over 98.9% of subjects for diphtheria, tetanus and hepatitis B. The vaccine response rate to pertussis antigen was at least 97.8% in each group. Overall, the DTPw-HBV/Hib2.5 [Kft] vaccine was well tolerated in healthy infants; no SAEs were reported in any group.The DTPw-HBV/Hib2.5 [Kft] vaccine was immunogenic and well-tolerated when administered according to the EPI schedule to Indian infants.http://www.clinicaltrials.gov NCT00473668." @default.
• W2034803529 created "2016-06-24" @default.
• W2034803529 creator A5000875812 @default.
• W2034803529 creator A5005776804 @default.
• W2034803529 creator A5015175297 @default.
• W2034803529 creator A5036140670 @default.
• W2034803529 creator A5052142743 @default.
• W2034803529 creator A5072039447 @default.
• W2034803529 creator A5091891690 @default.
• W2034803529 date "2010-10-15" @default.
• W2034803529 modified "2023-10-06" @default.
• W2034803529 title "The immunogenicity and safety of a reduced PRP-content DTPw-HBV/Hib vaccine when administered according to the accelerated EPI schedule" @default.
• W2034803529 cites W1973271409 @default.
• W2034803529 cites W1979841030 @default.
• W2034803529 cites W1981573468 @default.
• W2034803529 cites W2002119922 @default.
• W2034803529 cites W2006337457 @default.
• W2034803529 cites W2017683072 @default.
• W2034803529 cites W2029893167 @default.
• W2034803529 cites W2040828861 @default.
• W2034803529 cites W2042696935 @default.
• W2034803529 cites W2054298744 @default.
• W2034803529 cites W2075578848 @default.
• W2034803529 cites W2092663256 @default.
• W2034803529 cites W2107053699 @default.
• W2034803529 cites W2169717173 @default.
• W2034803529 cites W2171920166 @default.
• W2034803529 cites W2327918138 @default.
• W2034803529 cites W2134093180 @default.
• W2034803529 doi "https://doi.org/10.1186/1471-2334-10-298" @default.
• W2034803529 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2973939" @default.
• W2034803529 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20950457" @default.
• W2034803529 hasPublicationYear "2010" @default.
• W2034803529 type Work @default.
• W2034803529 sameAs 2034803529 @default.
• W2034803529 citedByCount "16" @default.
• W2034803529 countsByYear W20348035292012 @default.
• W2034803529 countsByYear W20348035292013 @default.
• W2034803529 countsByYear W20348035292015 @default.
• W2034803529 countsByYear W20348035292016 @default.
• W2034803529 countsByYear W20348035292018 @default.
• W2034803529 countsByYear W20348035292019 @default.
• W2034803529 countsByYear W20348035292021 @default.
• W2034803529 countsByYear W20348035292022 @default.
• W2034803529 countsByYear W20348035292023 @default.
• W2034803529 crossrefType "journal-article" @default.
• W2034803529 hasAuthorship W2034803529A5000875812 @default.
• W2034803529 hasAuthorship W2034803529A5005776804 @default.
• W2034803529 hasAuthorship W2034803529A5015175297 @default.
• W2034803529 hasAuthorship W2034803529A5036140670 @default.
• W2034803529 hasAuthorship W2034803529A5052142743 @default.
• W2034803529 hasAuthorship W2034803529A5072039447 @default.
• W2034803529 hasAuthorship W2034803529A5091891690 @default.
• W2034803529 hasBestOaLocation W20348035291 @default.
• W2034803529 hasConcept C126322002 @default.
• W2034803529 hasConcept C159047783 @default.
• W2034803529 hasConcept C187212893 @default.
• W2034803529 hasConcept C197934379 @default.
• W2034803529 hasConcept C203014093 @default.
• W2034803529 hasConcept C22070199 @default.
• W2034803529 hasConcept C2522874641 @default.
• W2034803529 hasConcept C2775876817 @default.
• W2034803529 hasConcept C2776029263 @default.
• W2034803529 hasConcept C2777382497 @default.
• W2034803529 hasConcept C2777410769 @default.
• W2034803529 hasConcept C2777704310 @default.
• W2034803529 hasConcept C2779583294 @default.
• W2034803529 hasConcept C2779592421 @default.
• W2034803529 hasConcept C2780572238 @default.
• W2034803529 hasConcept C2780593183 @default.
• W2034803529 hasConcept C2780799908 @default.
• W2034803529 hasConcept C2780868878 @default.
• W2034803529 hasConcept C2781037505 @default.
• W2034803529 hasConcept C71924100 @default.
• W2034803529 hasConcept C8891405 @default.
• W2034803529 hasConceptScore W2034803529C126322002 @default.
• W2034803529 hasConceptScore W2034803529C159047783 @default.
• W2034803529 hasConceptScore W2034803529C187212893 @default.
• W2034803529 hasConceptScore W2034803529C197934379 @default.
• W2034803529 hasConceptScore W2034803529C203014093 @default.
• W2034803529 hasConceptScore W2034803529C22070199 @default.
• W2034803529 hasConceptScore W2034803529C2522874641 @default.
• W2034803529 hasConceptScore W2034803529C2775876817 @default.
• W2034803529 hasConceptScore W2034803529C2776029263 @default.
• W2034803529 hasConceptScore W2034803529C2777382497 @default.
• W2034803529 hasConceptScore W2034803529C2777410769 @default.
• W2034803529 hasConceptScore W2034803529C2777704310 @default.
• W2034803529 hasConceptScore W2034803529C2779583294 @default.
• W2034803529 hasConceptScore W2034803529C2779592421 @default.
• W2034803529 hasConceptScore W2034803529C2780572238 @default.
• W2034803529 hasConceptScore W2034803529C2780593183 @default.
• W2034803529 hasConceptScore W2034803529C2780799908 @default.
• W2034803529 hasConceptScore W2034803529C2780868878 @default.
• W2034803529 hasConceptScore W2034803529C2781037505 @default.
• W2034803529 hasConceptScore W2034803529C71924100 @default.
• W2034803529 hasConceptScore W2034803529C8891405 @default.
• W2034803529 hasIssue "1" @default.
• W2034803529 hasLocation W20348035291 @default.
• W2034803529 hasLocation W20348035292 @default.
• W2034803529 hasLocation W20348035293 @default.

• next